Cart
sales@molnova.com
BTSA1
CAS No. 314761-14-3
BTSA1( —— )
Catalog No. M19903 CAS No. 314761-14-3
BTSA1 is a BAX activator that binds with high affinity and specificity to the N-terminal activation site and induces conformational changes to BAX leading to BAX-mediated apoptosis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 34 | In Stock |
|
| 5MG | 58 | In Stock |
|
| 10MG | 110 | In Stock |
|
| 25MG | 178 | In Stock |
|
| 50MG | 335 | In Stock |
|
| 100MG | 500 | In Stock |
|
| 500MG | 1098 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBTSA1
-
NoteResearch use only, not for human use.
-
Brief DescriptionBTSA1 is a BAX activator that binds with high affinity and specificity to the N-terminal activation site and induces conformational changes to BAX leading to BAX-mediated apoptosis.
-
DescriptionBTSA1 is a BAX activator that binds with high affinity and specificity to the N-terminal activation site and induces conformational changes to BAX leading to BAX-mediated apoptosis.
-
In VitroCell Viability Assaysup>Cell Line:Human AML cell linesIn VivoAnimal Model:NOD-SCID IL2Rγ null (NSG) mice (6-8 weeks old) with THP-1 cells Dosage:10 mg/kg Administration:Intraperitoneal injection; every two days Result:Significantly increased survival when compared to vehicle-treated mice.Synonyms——PathwayAngiogenesisTargetBcl-2RecptorBaxResearch Area——Indication——
Chemical Information
-
CAS Number314761-14-3
-
Formula Weight430.51
-
Molecular FormulaC21H14N6OS2
-
Purity>98% (HPLC)
-
SolubilityDMSO: 65 mg/mL
-
SMILESO=C1N(N=C(\C1=N/Nc1nccs1)c1ccccc1)c1nc(cs1)-c1ccccc1
-
Chemical Name1H-Pyrazole-45-dione 3-phenyl-1-(4-phenyl-2-thiazolyl)- 4-[2-(2-thiazolyl)hydrazone]
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Reyna DE et al. Direct Activation of BAX by BTSA1 Overcomes Apoptosis Resistance in Acute Myeloid Leukemia. Cancer Cell. 2017 Oct 9;32(4):490-505.e10.
molnova catalog
related products
-
CID5721353
BCL6 inhibitor 79-6 (Compound 79-6) is the first-generation, specific BCL6 BTB domain inhibitor with IC50 of 200 uM, Kd of 129 uM.
-
BT2
BT2 is a BCKDC kinase (BDK) inhibitor with an IC50 of 3.19 μM. BT2 (compound 4) is also a potent and selective Mcl-1 inhibitor with a Ki value of 59 μM.
-
BCL6-IN-3
BCL6-IN-3 is a potent BCL6 inhibitor with GI50 of 70 nM in SU-DHL4 cells. BCL6-in-3 regulates cell activation, differentiation, DNA damage and apoptosis, and has antitumor activity.
